2016 Fiscal Year Final Research Report
Development and clinical application of new liquid biopsy method in nasopharyngeal carcinoma
| Project/Area Number |
15K20190
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Otorhinolaryngology
|
|---|
| Research Institution | Kanazawa University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2015-04-01 – 2017-03-31
|
| Keywords | 上咽頭癌 / Epstein-Barr virus / miRNA / バイオマーカー |
|---|
| Outline of Final Research Achievements |
Epstein-Barr virus (EBV) -related RNA in serum was quantified using serum from 31 patients with nasopharyngeal carcinoma. We examined three BamHI A rightward transcripts (BART) miRNAs among BART miRNAs which are EBV-related RNA this time. As a result of comparing the quantitative results with the stage and recurrence of nasopharyngeal carcinoma patients, it was found that miR-BART17-5p reflects the prognosis of patients with nasopharyngeal carcinoma after treatment most.
|
| Free Research Field |
耳鼻咽喉科頭頸部外科
|
